Our findings suggest it is worth investigating whether Sulf2 could also be protective in other autoimmune conditions where IFNβ signaling promotes Th17-driven inflammation e.g. psoriasis, systemic lupus erythematosus, Sjögren’s syndrome, and neuromyelitis optica [57]. This evidence concerns the gene SULF2 and neuromyelitis optica.